Print page Resize text Change font-size Change font-size Change font-size High contrast

Home > News

ENCePP News Archive 2010

22 December 2010
ENCePP Work Plan 2011-2012

The ENCePP Steering Group has adopted the ENCePP Work Plan 2011-2012. Building on the initial phase of establishment, during 2011 and 2012 the priority will be to consolidate ENCePP as an important and internationally renowned resource in the field of pharmacovigilance and pharmacoepidemiology that delivers for health protection and promotion.

More details here >>

01 December 2010

Public Consultation - Summary of comments received

The comments received in response to the public consultations on the ENCePP Code of Conduct and the Checklist of Methodological Standards for ENCePP Study Protocols and their outcomes have been published on the ENCePP website.

For more information see:

- Overview of comments received: Code of Conduct

- Overview of comments received: Checklist of Methodological Standards

29 November 2010

Report of the 6th ENCePP Plenary

The report of the 6th ENCePP Plenary which took place at the European Medicines Agency on 18 November 2010 has been published.

More details here >>

18 November 2010

Launch of E-Register of Studies


On 18 November 2010, the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) launched the electronic ENCePP Register of Studies (E-Register of Studies) that aims to provide a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

Registration of studies in the E-Register of Studies is one of the "CoRe requirements" of being an "ENCEPP Study" and is, therefore, mandatory for “ENCePP Studies” only. All other studies, including those that do not qualify as an "ENCePP Study" (e.g. studies that have already started) can still register in the E-Register of Studies and their submission is encouraged.


For more information see:

 - Press Release

 - E-Register of Studies

 - ENCePP Studies

05 November 2010
Public Consultation: ENCePP Guide on Methodological Standards in Pharmacoepidemiology

On 5 November 2010, a public consultation was launched on a draft Guide on Methodological Standards in Pharmacoepidemiology. The Guide seeks to assure high quality pharmacoepidemiological "ENCePP Studies", to fuel learned regulatory decision making and to stimulate innovation that benefits patients and public health at large.

More details here >>

14 October 2010

ENCePP Plenary Meeting -18 November 2010

The next ENCePP Plenary meeting will take place on Thursday, 18 November 2010, 9.30-16.30 at the European Medicines Agency in London. ENCePP partners wishing to nominate a representative who will attend this event are invited to do so via the electronic pre-registration form.

For further information see:

Mandate and Rules of Procedure of the ENCePP Plenary

Draft Agenda

01 October 2010

European Medicines Agency awards first 'ENCePP study' seal for post-marketing study

The European Medicines Agency and the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) have awarded the first 'ENCePP study' seal to an observational study investigating the "long-term outcomes and adverse events of therapy with inhaled corticosteroids, long-acting beta-2-agonists and anticholinergic drugs in hospitalised patients with Chronic Obstructive Pulmonary Disease (COPD)". The study is coordinated by the Department of Epidemiology, Lazio Regional Health Service.

For further information see: Press release published on 1st October 2010

12 September 2010

ENCePP Code of Conduct - Revision 1

On 12 September 2010 the ENCePP Steering Group adopted a revision of the Code of Conduct and implementation guidance to clarify the conditions of providing access to study data.

For further information see: ENCePP Code of Conduct


DIA ENCePP Information Day

The DIA ENCePP Information Day will take place on 26 November 2010
at De Vere Venues Canary Wharf, London.

For further information and detailed programme see:
- ENCePP Information Day Programme

To register for this event, please visit the DIA website.


Funding Opportunities for Adverse Drug Reaction Research through the European Commission's 7th Framework Programme

In an effort to stimulate collaboration and thus facilitate the establishment of consortia, the ENCePP Secretariat has created a new section in the ENCePP partners' forum entitled "FP7 5th Call", with subsections for each topic. We hope this will give ENCePP partners the opportunity to express their interest in participating (or even leading a project consortium!)  in each individual topic.

For further information see: Announcement of EMA priorities - 5th Call FP7

Release of version 2 of the ENCePP Database of Research Resources to include a new Data Source database
ENCePP Workplan 2010


>> Back to News